INBS
Intelligent Bio Solutions Inc.
NASDAQHealthcareMedical - Diagnostics & ResearchUS
Rating:C
Company Profile
CEO
Harry Simeonidis
IPO Date
2020-12-23
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Intelligent Bio Solutions Inc.
CEO
Harry Simeonidis
IPO Date
2020-12-23
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
| 5,000 |
| $0.00 |
| 20 Mar 2026 | Sakiris Spiro Kevin | Chief Financial Officer | A-Award | Acquired | 9,150 | $0.00 |
| 20 Mar 2026 | Sakiris Spiro Kevin | Chief Financial Officer | A-Award | Acquired | 21,350 | $0.00 |
| 20 Mar 2026 | Hurd Jonathan Scott | director | A-Award | Acquired | 5,000 | $0.00 |
| 20 Mar 2026 | Isenberg Jason | director | A-Award | Acquired | 5,000 | $0.00 |
| 20 Mar 2026 | Simeonidis Harry | Chief Executive Officer | A-Award | Acquired | 9,150 | $0.00 |
| 20 Mar 2026 | Simeonidis Harry | Chief Executive Officer | A-Award | Acquired | 21,350 | $0.00 |
| 6 Oct 2023 | TOWERS CHRISTOPHER | director | P-Purchase | Acquired | 9,090 | $0.55 |
| 6 Oct 2023 | TOWERS CHRISTOPHER | director | P-Purchase | Acquired | 9,090 | $0.00 |